Posted on November 1st, 2009 by Health News
UroToday.com - Pelvic floor disorders such as incontinence and prolapse are common bothersome conditions that can be initially and successfully addressed with conservative patient-initiated methods such as pelvic floor muscle and bladder retraining exercises. Women need to be well informed regarding these treatment options. Unfortunately, previous research shows that many women do not [...]
No Comments »
Filed under: Women's Health
Posted on November 1st, 2009 by Health News
Amgen today announced the publication of results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy), a large, randomized, double-blind, placebo-controlled, Phase 3 pivotal study of patients with chronic kidney disease (CKD) not on dialysis, moderate anemia and type-2 diabetes.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV- (guanfacine) Extended Release Tablets, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, and Daytrana- (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Shire plc, the global specialty biopharmaceutical company, today announced findings at a major medical meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana® (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Shire plc, the global specialty biopharmaceutical company, announced new study results on INTUNIV- (guanfacine) Extended Release Tablets, at a major psychiatric medical meeting today.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Schering-Plough Corp. announced today the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company’s supplemental Biologics License Application regarding PEGINTRON® (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Quintiles today announced a strategic alliance with leading global pharmaceutical company Eisai Co., Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. Under the terms of the agreement, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor indications. A key goal of the alliance is to determine [...]
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
NovaBay Pharmaceuticals, Inc. today announced that its Aganocide® compounds demonstrate potent antifungal activity in an established pre-clinical infected nail model of onychomycosis. The study data will be presented tomorrow at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from multiple clinical and preclinical studies evaluating Hematide, including preliminary results of a Phase 2 trial which demonstrated that Hematide increased hemoglobin levels in a group of anemic hemodialysis (HD) patients.
No Comments »
Filed under: Pharmacy News
Posted on November 1st, 2009 by Health News
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type [...]
No Comments »
Filed under: Pharmacy News
